<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> is a <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e> with the histopathological correlate of leukocytoclastic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The classification criteria for the disease include the presence of recurrent oral aphthous <z:mpath ids='MPATH_579'>ulcers</z:mpath> combined with at least two other manifestations, such as genital aphthous <z:mpath ids='MPATH_579'>ulcers</z:mpath>, skin manifestations (mostly <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosa or <z:e sem="disease" ids="C0406191" disease_type="Disease or Syndrome" abbrv="">pseudofolliculitis</z:e>) and ocular manifestations (<z:hpo ids='HP_0012121'>panuveitis</z:hpo> or <z:hpo ids='HP_0012123'>posterior uveitis</z:hpo> with <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo>) </plain></SENT>
<SENT sid="2" pm="."><plain>A positive <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test is regarded as pathognomonic for the disease and a <z:mp ids='MP_0001924'>sterile</z:mp> papulopustule occurs after a <z:mp ids='MP_0001924'>sterile</z:mp> needle prick of the forearm </plain></SENT>
<SENT sid="3" pm="."><plain>However, this test is positive in only 15% of the patients </plain></SENT>
<SENT sid="4" pm="."><plain>The prognosis of <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> becomes unfavorable when vital organs are involved </plain></SENT>
<SENT sid="5" pm="."><plain>This is the case for involvement of the central <z:mp ids='MP_0008912'>nervous</z:mp> system which occurs in 10% of patients, arterial and pulmonary arterial <z:hpo ids='HP_0002617'>aneurysms</z:hpo> and gastrointestinal involvement, which clinically and histopathologically is difficult to differentiate from <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> but tends to perforate </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0409702" disease_type="Disease or Syndrome" abbrv="">Oligoarthritis</z:e>, which occurs in approximately 50% of the patients, causes problems concerning the differential diagnosis from classical forms of <z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondyloarthritis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> is associated with HLA-B51 in 50-80% of the cases depending on the country of origin of the patient </plain></SENT>
<SENT sid="8" pm="."><plain>The prognosis becomes unfavorable if the disease manifests in young male patients </plain></SENT>
<SENT sid="9" pm="."><plain>The treatment of extraocular manifestations depends on the <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Milder manifestations are treated with low dose <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and steroid sparing <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi>, such as <z:chebi fb="2" ids="2948">azathioprine</z:chebi> or <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A </plain></SENT>
<SENT sid="11" pm="."><plain>In cases with more severe manifestations, such as central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) involvement <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> or TNF <z:chebi fb="68" ids="48706">antagonists</z:chebi> and in selected cases also interferon alpha can be considered </plain></SENT>
</text></document>